NAAG Presidential Initiative Attorney General George Jepsen Challenges

NAAG Presidential Initiative Attorney General George Jepsen Challenges in Health Care Cost, Competition and Policy Innovation

Goals: • To help Attorneys General “unpack” complex challenges in health care marketplace. • To generate broad, bipartisan discussion among key players on healthcare policy.

Focus: • Keynote speeches and panel topics will focus on three main themes: 1. Cost 2. Competition 3. Innovation • Purpose: To identify challenges, highlight trends and explore innovative approaches

Presenters: Keynote speakers and Panelists are being chosen for their expertise and dynamic perspectives on themes and related topics. They will include: 1. National health care leaders from industry, government, academia and public policy groups. 2. Experts in the health care field. •

Planning: Meetings are underway to solicit input on topics. Invited to participate are: • • • Healthcare industry trade associations (e. g. , AHIP, AHA, AMA, Ph. ARMA) Health insurance companies Pharmaceutical companies Hospitals Physicians Research and policy institutes (e. g. , U. S. Chamber of Commerce, Bipartisan Policy Center, The Heritage Foundation, Brookings Institution, Robert Wood Johnson Foundation) Private attorneys representing healthcare industry clients Academic experts in healthcare policy, law, economics Consumer advocates Government officials (States, DOJ, FTC)

First Up: Fall Meeting, Nov. 28 -30 Two panels of particular interest to AGs: • 1. Health Care Consolidation: Antitrust Review and Enforcement Update • 2. Pharmaceuticals: Issues Affecting Cost and Competition

Fall Meeting, Nov. 28 -30 Panel 1: Health Care Consolidation: Antitrust Review and Enforcement Update 1. Insurance market concentration: Lessons learned from recent state and federal reviews of proposed insurance company mergers. 2. Hospitals & horizontal integration: The role of antitrust regulators as illustrated by recent cases. 3. Physician practices & vertical integration: Recent antitrust reviews and new approaches.

Fall Meeting, Nov. 28 -30 Panel 2: Pharmaceuticals: Issues Affecting Cost and Competition 1. Consolidation of pharmaceutical companies –brand generic 2. Pay for delay in manufacture of generic drugs 3. REMS (Risk Evaluation and Mitigation Strategies) as barrier to generic drug market entry

Topics Under Consideration for upcoming meetings • Policy innovation at the • Fee-for-service vs. value state-level -based provider payment models • Drivers and impacts of • Healthcare data industry consolidation transparency • Innovative approaches • Future reform to control costs approaches • Prescription drug pricing

Plan Ahead: Winter Meeting: Washington, DC Feb. 27 -March 1, 2017; Summit Meeting: New York City April 26 -28, 2017; Summer Meeting: TBD June 20 -22, 2017

Conclusion: Attorney General Jepsen welcomes your comments and suggestions: Potential panelists and keynote speakers; Topics of particular interest or concern;

Questions and/or Comments? Thank You Deputy Attorney General Perry Zinn Rowthorn Contact me: perryzr@ct. gov